ABCL Abcellera Biologics Inc
Company Analysis
Latest News
🔴 Abcellera Biologics falls 4.1% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🔴 Abcellera Biologics is trading 4.56% down in pre-market as hotter-than-expected U.S. inflation raises rate-hike concerns
Abcellera Biologics is trading at $11.81, down 4.56% in pre-market on October 15 amid broader risk-off sentiment after hotter-than-expected U.S. inflation...
🟢 Abcellera Biologics is trading 4.3% up in pre-market
Abcellera Biologics is trading 4.3% up at $13.08 in pre-market on October 12; the cause remains unclear. - No fresh company announcement or reliable report...
🟢 Abcellera Biologics rises 5.0% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 Abcellera Biologics is trading 4.1% down today with no clear company-specific explanation
Abcellera Biologics is trading 4.1% down now at $12.31, with no clear company-specific announcement explaining the October 8 decline surfaced in available...
🔴 Abcellera Biologics is trading 4.1% down today amid biotech-sector weakness
Abcellera Biologics is trading at $13.21, down 4.14%, with biotech-sector weakness providing context, but no clear company-specific explanation was...
🟢 Abcellera Biologics is trading 4.43% up with no company-specific catalyst identified
Abcellera Biologics is trading 4.43% up at $14.39 as of 9:43 a.m. EST on October 6, 2026; no new company-specific announcement explaining the move was found. -...
🔴 Abcellera Biologics is trading 4.22% down — no clear catalyst identified
Abcellera Biologics is trading 4.22% down at $13.97, with no clear catalyst identified for the October 1 decline. - The scheduled ABCL635 Phase 2 data...
🟢 Abcellera Biologics is trading 4.3% up today after JPMorgan's Overweight initiation and $17 target
Abcellera Biologics is trading 4.34% up at $14.52 after JPMorgan initiated coverage with an Overweight rating and a $17 target, cited as the immediate...
🟢 Abcellera Biologics is trading 10.7% up with no clear company-specific catalyst
Abcellera Biologics is trading 10.7% up at $14.05, though the cause of the intraday rise remains unclear. - No clear new company-specific announcement on...
🟢 Abcellera Biologics is trading 4.17% up; catalyst remains unclear
Abcellera Biologics is trading at $13.23, up 4.17%, with the specific reason for its September 28 intraday rise still unclear. - No clear company-specific...
🔴 Abcellera Biologics is trading 4.06% down today as 10-year Treasury yield hits a 19-year high
Abcellera Biologics is trading 4.06% down at $11.81, with macro-driven inflation and higher-for-longer rate concerns pressuring biotech valuations. - The...
🔴 Abcellera Biologics is trading 4.1% down today as rising oil and Treasury yields pressure valuations
Abcellera Biologics is trading 4.1% lower at $12.13 as rising crude oil prices and a 4.99% 10-year Treasury yield pressure equity valuations. - No fresh...
🟢 Abcellera Biologics is trading 11.47% up today after announcing an ABCL635 Phase 2 data presentation
Abcellera Biologics is trading at $13.01, up +11.47%, after announcing on September 16, 2026, that it will present Phase 2 data for ABCL635 at the...
Abcellera's Hot-Flash Drug Sends Shares Soaring — But Can a Single Shot Justify a $3.8 Billion Bet?
Shares of AbCellera Biologics surged +7.5% to $12.55 on September 17 after the company announced it will present Phase 2 clinical data for its lead menopause...
🟢 Abcellera Biologics is trading 7.5% up today after announcing Phase 2 ABCL635 data presentation
Abcellera Biologics is trading at $12.55 (+7.54%) after announcing it will present Phase 2 ABCL635 data at the IMS World Congress on Menopause. - The...
🟢 Abcellera Biologics is trading 6% up today amid biotech-sector rally after Fed decision
Abcellera Biologics is trading 6% up at $12.37, primarily supported by a 2.55% biotech-sector rally and stronger market sentiment following the Federal Reserve...
🟢 Abcellera Biologics Inc is trading 4.48% up
ABCL is trading at $11.67, up 4.48%.
🟢 Abcellera Biologics is trading 4.16% up today as broader markets rally after inflation data
Abcellera Biologics is trading 4.16% up at $10.89 as broader markets rally after inflation data. - The S&P 500, Nasdaq Composite, and Dow Jones are each up...
🔴 Abcellera Biologics is trading 4% down today as risk-off selling pressures growth stocks
Abcellera Biologics is trading at $10.60, down 4.07%, as broader risk-off selling pressured growth stocks on September 10, 2026. - The S&P 500, Nasdaq...